Paediatr Child Health 6(6):329335 Azari AA, Barney NP (2013) Conjunctivitis: a systematic review of diagnosis and treatment
A 2024 retrospective cohort analysis published in Diabetes, Obesity and Metabolism (N=312 patients who switched from semaglutide to tirzepatide at a single academic center) found that switchers lost an additional mean of 6.3% of body weight over 6 months after the switch, with 68% reporting either stable or improved GI tolerability [12]
However, a 2024 study analyzing global pharmacovigilance data found a higher-than-expected number of suicidal ideation reports among semaglutide users compared to other diabetes medications
Furthermore, with recent manufacturer price cuts and discount programs, saving money on GLP-1 treatment has never been easier
When you consult a clinic, ask directly whether their glutathione product carries a DRAP registration number
JH: Conceptualization, Funding acquisition, Visualization, Writing review and editing